Skip to main content
Figure 5 | BMC Veterinary Research

Figure 5

From: Reduction of porcine circovirus type 2 (PCV2) viremia by a reformulated inactivated chimeric PCV1-2 vaccine-induced humoral and cellular immunity after experimental PCV2 challenge

Figure 5

Lymphocyte subsets analysis in the different groups; CD3+(■) and CD4+(□) from vaccinated challenged (T01) animals, CD3+(▲) and CD4+(△) from vaccinated non-challenged (T02) animals, CD3+(●) and CD4+(◯) from non-vaccinated challenged (T03) animals, and CD3+(♦) and CD4+(◇) from non-vaccinated non-challenged (T04) animals. Variation is expressed as the standard deviation. Significant difference (T01 and T02 vs. T03 and T04) is indicated at p value <0.05*. Significant difference (T02 vs. T03) is indicated at p value <0.05†.

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us